MORGAN STANLEY PLC/CALL/PFIZER INC/62/0.1/17.01.25 Stock

Warrant

DE000MB32H16

Market Closed - Börse Stuttgart 14:46:56 2024-05-27 EDT
0.008 EUR -11.11% Intraday chart for MORGAN STANLEY PLC/CALL/PFIZER INC/62/0.1/17.01.25
Current month-38.46%
1 month-33.33%
Date Price Change
24-05-27 0.008 -11.11%
24-05-24 0.009 0.00%
24-05-23 0.009 0.00%
24-05-22 0.009 0.00%
24-05-21 0.009 0.00%

Delayed Quote Börse Stuttgart

Last update May 27, 2024 at 02:46 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer Morgan Stanley
WKN MB32H1
ISINDE000MB32H16
Date issued 2023-02-01
Strike 62 $
Maturity 2025-01-17 (235 Days)
Parity 10 : 1
Emission price 0.18
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.17
Lowest since issue 0.005
Spread 0.032
Spread %80.00%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.88 USD
Average target price
31.92 USD
Spread / Average Target
+10.51%
Consensus